[1]. Mathew, D., & Hsu, W. (2018) Antiviral potential of curcumin, Journal of Functional Foods, vol. 40, pp. 692–699.
[2]. Mofidi Najjar, F., Taghavi, F., Ghadari, R., Sheibani, N., & Moosavi-Movahedi, A. A. (2017) Destructive effect of non-enzymatic glycation on catalase and remediation via curcumin, Archives of Biochemistry and Biophysics, vol. 630, pp. 81–90.
[3]. Zhu, L., Ding, X., Zhang, D., Yuan, CH., Wang, J., Ndegwa, E., & Zhu, G. (2013) Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells, Acta Virologica, vol. 57, no. 4, pp. 389–396.
[4]. Noureddin, S. A., El-Shishtawy, R. M., & Al-Footy, K. O. (2019) Curcumin analogues and their hybrid molecules as multifunctional drugs, European Journal of Medicinal Chemistry, vol. 182, pp. 111631-111671.
[5]. Li, H., Zhong, C., Wang, Q., Chen, W., & Yuan, Y. (2019) Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis, Antiviral Research, vol. 167, pp. 98–103.
[6]. Shinojima, N., Yokoyama, T., Kondo, Y., & Kondo, S. (2007) Erratum: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy (Autophagy), Autophagy, vol. 3, no. 6. pp. 635–637.
[7]. Shome, S., Das, A., Dutta, M., & Kanti, M. (2016) Curcumin as potential therapeutic natural product : a nanobiotechnological perspective, Journal of Pharmacy and Pharmacology, vol. 68, pp. 1481–1500.
[8]. Lv, Y., Lei, N., Wang, D., An, Z., Li, G., Han, F., Liu, H., & Liu, L. (2014) Protective effect of curcumin against cytomegalovirus infection in Balb/c mice, Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 1140–1147.
[9]. Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017) Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding, Antiviral Research, vol. 142, pp. 148–157.
[10]. Von Rhein, C., Weidner, T., Henß, L., Martin, J., Weber, C., Sliva, K., & Schnierle, B. S. (2016) Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro, Antiviral Research, vol. 125, pp. 51–57.
[11]. Chen, T. Y., Chen, D.Y., Wen, H. W., Ou, J. L., Chiou, S. S., Chen, J. M., Wong, M. L., & Hsu, W. L. (2013) Inhibition of Enveloped Viruses Infectivity by Curcumin, PLoS One, vol. 8, no. 5, pp. 1–11.
[12]. Anggakusuma, Colpitts, C. C., Schang, L., M. Rachmawati, H., Frentzen, A., Pfaender, S., Behrendt, P., Brown, R. J. P., Bankwitz, D., Steinmann, J., Ott, M., Meuleman, P., Rice, A., Ploss, C. M., Pietschmann, T., & Steinmann, E. (2014) Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells, Gut, vol. 63, no. 7, pp. 1137–1149.
[13]. Yang, M., Lee, G., Si, J., Lee, S., You, H. J., & Ko, G. (2016) Curcumin Shows Antiviral Properties against Norovirus, Molecule, vol. 21, no. 10, pp. 1401–1415.
[14]. Sui, Z., Salto, R., Li, J., Craik, C., & de Montellano, P. R. O. (1993) Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes, Bioorganic & Medicinal Chemistry, vol. 1, no. 6, pp. 415–422.
[15]. Mazumder, A., Raghavan, K., Weinstein, J., Kohn, K. W., & Pommier, Y. (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochemical Pharmacology, vol. 49, no. 8, pp. 1165–1170.
[16]. Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) Anti-infective properties of the golden spice curcumin, Frontiers in Microbiology, vol. 10, pp. 912-928.
[17]. Ali, A., & Banerjea, A. C. (2016) “Curcumin inhibits HIV-1 by promoting Tat protein degradation, Scientific Reports, vol. 6, pp. 1–9.
[18]. Kim, K. J., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. H. (2010) Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway, FEBS Letters, vol. 584, no. 4, pp. 707–712.
[19]. Ludwig S., & Planz, O. (2008) Influenza viruses and the NF-κB signaling pathway - Towards a novel concept of antiviral therapy, Biological Chemistry, vol. 389, no. 10, pp. 1307–1312.
[20]. Chen, D. Y., Shien, J. H., Tiley, L., Chiou, S. S., Wang, S. Y., Chang, T. J., Lee, Y. J., Chan, K. W., & Hsu, W. L. (2010) Curcumin inhibits influenza virus infection and haemagglutination activity, Food Chemistry, vol. 119, no. 4, pp. 1346–1351.
[21]. Ou, J. L., Mizushina, Y., Wang, S. Y., Chuang, D. Y., Nadar, M., & Hsu, W. L. (2013) Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity, FEBS Journal, vol. 280, no. 22, pp. 5829–5840.
[22]. Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Das, R., Baer, A., Bethel, L., Ture, M., Hartman, A. L., Das, B., Bailey, C., & Kashanchi, F. (2012) Curcumin inhibits rift valley fever virus replication in human cells, Journal of Biological Chemistry, vol. 287, no. 40, pp. 33198–33214.
[23]. Obata, K., Kojima, T., Masaki, T., Okabayashi, T., Yokota, S., Hirakawa, S., Nomura, K., Takasawa, A., Murata, M., Tanaka, S., Fuchimoto, J., Fujii, N., Tsutsumi, H., Himi, T., & Sawada, N. (2013) Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells, PLoS One, vol. 8, no. 9, pp. 1–14.
[24]. Zhang, Y., Wang, Z., Chen, H., Chen, Z., & Tian, Y. (2014) Antioxidants: Potential antiviral agents for Japanese encephalitis virus infection, International Journal of Infectious Diseases, vol. 24, pp. 30–36.
[25]. Dutta, K., Ghosh, D., & Basu, A. (2009) Curcumin protects neuronal cells from japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system, Journal of Neuroimmune Pharmacology, vol. 4, no. 3, pp. 328–337.
[1]. Mathew, D., & Hsu, W. (2018) Antiviral potential of curcumin, Journal of Functional Foods, vol. 40, pp. 692–699.
[2]. Mofidi Najjar, F., Taghavi, F., Ghadari, R., Sheibani, N., & Moosavi-Movahedi, A. A. (2017) Destructive effect of non-enzymatic glycation on catalase and remediation via curcumin, Archives of Biochemistry and Biophysics, vol. 630, pp. 81–90.
[3]. Zhu, L., Ding, X., Zhang, D., Yuan, CH., Wang, J., Ndegwa, E., & Zhu, G. (2013) Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells, Acta Virologica, vol. 57, no. 4, pp. 389–396.
[4]. Noureddin, S. A., El-Shishtawy, R. M., & Al-Footy, K. O. (2019) Curcumin analogues and their hybrid molecules as multifunctional drugs, European Journal of Medicinal Chemistry, vol. 182, pp. 111631-111671.
[5]. Li, H., Zhong, C., Wang, Q., Chen, W., & Yuan, Y. (2019) Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis, Antiviral Research, vol. 167, pp. 98–103.
[6]. Shinojima, N., Yokoyama, T., Kondo, Y., & Kondo, S. (2007) Erratum: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy (Autophagy), Autophagy, vol. 3, no. 6. pp. 635–637.
[7]. Shome, S., Das, A., Dutta, M., & Kanti, M. (2016) Curcumin as potential therapeutic natural product : a nanobiotechnological perspective, Journal of Pharmacy and Pharmacology, vol. 68, pp. 1481–1500.
[8]. Lv, Y., Lei, N., Wang, D., An, Z., Li, G., Han, F., Liu, H., & Liu, L. (2014) Protective effect of curcumin against cytomegalovirus infection in Balb/c mice, Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 1140–1147.
[9]. Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017) Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding, Antiviral Research, vol. 142, pp. 148–157.
[10]. Von Rhein, C., Weidner, T., Henß, L., Martin, J., Weber, C., Sliva, K., & Schnierle, B. S. (2016) Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro, Antiviral Research, vol. 125, pp. 51–57.
[11]. Chen, T. Y., Chen, D.Y., Wen, H. W., Ou, J. L., Chiou, S. S., Chen, J. M., Wong, M. L., & Hsu, W. L. (2013) Inhibition of Enveloped Viruses Infectivity by Curcumin, PLoS One, vol. 8, no. 5, pp. 1–11.
[12]. Anggakusuma, Colpitts, C. C., Schang, L., M. Rachmawati, H., Frentzen, A., Pfaender, S., Behrendt, P., Brown, R. J. P., Bankwitz, D., Steinmann, J., Ott, M., Meuleman, P., Rice, A., Ploss, C. M., Pietschmann, T., & Steinmann, E. (2014) Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells, Gut, vol. 63, no. 7, pp. 1137–1149.
[13]. Yang, M., Lee, G., Si, J., Lee, S., You, H. J., & Ko, G. (2016) Curcumin Shows Antiviral Properties against Norovirus, Molecule, vol. 21, no. 10, pp. 1401–1415.
[14]. Sui, Z., Salto, R., Li, J., Craik, C., & de Montellano, P. R. O. (1993) Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes, Bioorganic & Medicinal Chemistry, vol. 1, no. 6, pp. 415–422.
[15]. Mazumder, A., Raghavan, K., Weinstein, J., Kohn, K. W., & Pommier, Y. (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochemical Pharmacology, vol. 49, no. 8, pp. 1165–1170.
[16]. Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) Anti-infective properties of the golden spice curcumin, Frontiers in Microbiology, vol. 10, pp. 912-928.
[17]. Ali, A., & Banerjea, A. C. (2016) “Curcumin inhibits HIV-1 by promoting Tat protein degradation, Scientific Reports, vol. 6, pp. 1–9.
[18]. Kim, K. J., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. H. (2010) Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway, FEBS Letters, vol. 584, no. 4, pp. 707–712.
[19]. Ludwig S., & Planz, O. (2008) Influenza viruses and the NF-κB signaling pathway - Towards a novel concept of antiviral therapy, Biological Chemistry, vol. 389, no. 10, pp. 1307–1312.
[20]. Chen, D. Y., Shien, J. H., Tiley, L., Chiou, S. S., Wang, S. Y., Chang, T. J., Lee, Y. J., Chan, K. W., & Hsu, W. L. (2010) Curcumin inhibits influenza virus infection and haemagglutination activity, Food Chemistry, vol. 119, no. 4, pp. 1346–1351.
[21]. Ou, J. L., Mizushina, Y., Wang, S. Y., Chuang, D. Y., Nadar, M., & Hsu, W. L. (2013) Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity, FEBS Journal, vol. 280, no. 22, pp. 5829–5840.
[22]. Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Das, R., Baer, A., Bethel, L., Ture, M., Hartman, A. L., Das, B., Bailey, C., & Kashanchi, F. (2012) Curcumin inhibits rift valley fever virus replication in human cells, Journal of Biological Chemistry, vol. 287, no. 40, pp. 33198–33214.
[23]. Obata, K., Kojima, T., Masaki, T., Okabayashi, T., Yokota, S., Hirakawa, S., Nomura, K., Takasawa, A., Murata, M., Tanaka, S., Fuchimoto, J., Fujii, N., Tsutsumi, H., Himi, T., & Sawada, N. (2013) Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells, PLoS One, vol. 8, no. 9, pp. 1–14.
[24]. Zhang, Y., Wang, Z., Chen, H., Chen, Z., & Tian, Y. (2014) Antioxidants: Potential antiviral agents for Japanese encephalitis virus infection, International Journal of Infectious Diseases, vol. 24, pp. 30–36.
[25]. Dutta, K., Ghosh, D., & Basu, A. (2009) Curcumin protects neuronal cells from japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system, Journal of Neuroimmune Pharmacology, vol. 4, no. 3, pp. 328–337.
[26]. Si, X., Wang, Y., Wong, J., Zhang, J., McManus, B. M., & Luo, H. (2007) Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication, Journal of Virology, vol. 81, no. 7, pp. 3142–3150.
[27]. Qin, Y., Lina, L., Chen, Y., Wu, S., Si, X., Wu, H., Zhai, X., Wang, Y., Tong, L., Pan, B., Zhong, X., Wang, T., Zhao, W., & Zhong, Z. (2014) Curcumin inhibits the replication of enterovirus 71 in vitro, Acta Pharmaceutica Sinica B, vol. 4, no. 4, pp. 284–294.
[28]. Rechtman, M. M., Har-Noy, O., Bar-Yishay, I., Fishman, S., Adamovich, Y., Shaul, Y., Halpern, Z., & Shloma, A. (2010) Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α, FEBS Letters, vol. 584, no. 11, pp. 2485–2490.
[29]. Kutluay, S. B., Doroghazi, J., Roemer, M. E., & Triezenberg, S. J. (2008) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity, Virology, vol. 373, no. 2, pp. 239–247.
[30]. Mishra A., & Das, B. C. (2015) Curcumin as an anti-human papillomavirus and anti-cancer compound, Future Oncology, vol. 11, no. 18, pp. 2487–2490
[31]. Teymouri, M., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features, BioFactors, vol. 43, no. 3, pp. 331–346.
[32]. Wen, C. C., Kuo, Y. H., Jan, J. T., Liang, P. H., Wang, S. Y., Liu, H. G., Lee, C. K., Chang, C. J., Kuo, S. T., Lee, S. S., Hou, C. C., Hsiao, P. W., Chien, S. C., Shyur L. F., & Yang, N. S. (2007) Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus, Journal of Medicinal Chemistry, vol. 50, no. 17, pp. 4087–4095.
[33]. Kandeel M., & Al-Nazawi, M. (2020) Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease, Life Sciences, vol. 251, pp. 117627-117632.
[34]. Elfiky, A. A. (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19, Life Sciences, vol. 248, pp 117477-117483.
[1]. Mathew, D., & Hsu, W. (2018) Antiviral potential of curcumin, Journal of Functional Foods, vol. 40, pp. 692–699.
[2]. Mofidi Najjar, F., Taghavi, F., Ghadari, R., Sheibani, N., & Moosavi-Movahedi, A. A. (2017) Destructive effect of non-enzymatic glycation on catalase and remediation via curcumin, Archives of Biochemistry and Biophysics, vol. 630, pp. 81–90.
[3]. Zhu, L., Ding, X., Zhang, D., Yuan, CH., Wang, J., Ndegwa, E., & Zhu, G. (2013) Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells, Acta Virologica, vol. 57, no. 4, pp. 389–396.
[4]. Noureddin, S. A., El-Shishtawy, R. M., & Al-Footy, K. O. (2019) Curcumin analogues and their hybrid molecules as multifunctional drugs, European Journal of Medicinal Chemistry, vol. 182, pp. 111631-111671.
[5]. Li, H., Zhong, C., Wang, Q., Chen, W., & Yuan, Y. (2019) Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis, Antiviral Research, vol. 167, pp. 98–103.
[6]. Shinojima, N., Yokoyama, T., Kondo, Y., & Kondo, S. (2007) Erratum: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy (Autophagy), Autophagy, vol. 3, no. 6. pp. 635–637.
[7]. Shome, S., Das, A., Dutta, M., & Kanti, M. (2016) Curcumin as potential therapeutic natural product : a nanobiotechnological perspective, Journal of Pharmacy and Pharmacology, vol. 68, pp. 1481–1500.
[8]. Lv, Y., Lei, N., Wang, D., An, Z., Li, G., Han, F., Liu, H., & Liu, L. (2014) Protective effect of curcumin against cytomegalovirus infection in Balb/c mice, Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 1140–1147.
[9]. Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017) Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding, Antiviral Research, vol. 142, pp. 148–157.
[10]. Von Rhein, C., Weidner, T., Henß, L., Martin, J., Weber, C., Sliva, K., & Schnierle, B. S. (2016) Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro, Antiviral Research, vol. 125, pp. 51–57.
[11]. Chen, T. Y., Chen, D.Y., Wen, H. W., Ou, J. L., Chiou, S. S., Chen, J. M., Wong, M. L., & Hsu, W. L. (2013) Inhibition of Enveloped Viruses Infectivity by Curcumin, PLoS One, vol. 8, no. 5, pp. 1–11.
[12]. Anggakusuma, Colpitts, C. C., Schang, L., M. Rachmawati, H., Frentzen, A., Pfaender, S., Behrendt, P., Brown, R. J. P., Bankwitz, D., Steinmann, J., Ott, M., Meuleman, P., Rice, A., Ploss, C. M., Pietschmann, T., & Steinmann, E. (2014) Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells, Gut, vol. 63, no. 7, pp. 1137–1149.
[13]. Yang, M., Lee, G., Si, J., Lee, S., You, H. J., & Ko, G. (2016) Curcumin Shows Antiviral Properties against Norovirus, Molecule, vol. 21, no. 10, pp. 1401–1415.
[14]. Sui, Z., Salto, R., Li, J., Craik, C., & de Montellano, P. R. O. (1993) Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes, Bioorganic & Medicinal Chemistry, vol. 1, no. 6, pp. 415–422.
[15]. Mazumder, A., Raghavan, K., Weinstein, J., Kohn, K. W., & Pommier, Y. (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochemical Pharmacology, vol. 49, no. 8, pp. 1165–1170.
[16]. Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) Anti-infective properties of the golden spice curcumin, Frontiers in Microbiology, vol. 10, pp. 912-928.
[17]. Ali, A., & Banerjea, A. C. (2016) “Curcumin inhibits HIV-1 by promoting Tat protein degradation, Scientific Reports, vol. 6, pp. 1–9.
[18]. Kim, K. J., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. H. (2010) Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway, FEBS Letters, vol. 584, no. 4, pp. 707–712.
[19]. Ludwig S., & Planz, O. (2008) Influenza viruses and the NF-κB signaling pathway - Towards a novel concept of antiviral therapy, Biological Chemistry, vol. 389, no. 10, pp. 1307–1312.
[20]. Chen, D. Y., Shien, J. H., Tiley, L., Chiou, S. S., Wang, S. Y., Chang, T. J., Lee, Y. J., Chan, K. W., & Hsu, W. L. (2010) Curcumin inhibits influenza virus infection and haemagglutination activity, Food Chemistry, vol. 119, no. 4, pp. 1346–1351.
[21]. Ou, J. L., Mizushina, Y., Wang, S. Y., Chuang, D. Y., Nadar, M., & Hsu, W. L. (2013) Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity, FEBS Journal, vol. 280, no. 22, pp. 5829–5840.
[22]. Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Das, R., Baer, A., Bethel, L., Ture, M., Hartman, A. L., Das, B., Bailey, C., & Kashanchi, F. (2012) Curcumin inhibits rift valley fever virus replication in human cells, Journal of Biological Chemistry, vol. 287, no. 40, pp. 33198–33214.
[23]. Obata, K., Kojima, T., Masaki, T., Okabayashi, T., Yokota, S., Hirakawa, S., Nomura, K., Takasawa, A., Murata, M., Tanaka, S., Fuchimoto, J., Fujii, N., Tsutsumi, H., Himi, T., & Sawada, N. (2013) Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells, PLoS One, vol. 8, no. 9, pp. 1–14.
[24]. Zhang, Y., Wang, Z., Chen, H., Chen, Z., & Tian, Y. (2014) Antioxidants: Potential antiviral agents for Japanese encephalitis virus infection, International Journal of Infectious Diseases, vol. 24, pp. 30–36.
[25]. Dutta, K., Ghosh, D., & Basu, A. (2009) Curcumin protects neuronal cells from japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system, Journal of Neuroimmune Pharmacology, vol. 4, no. 3, pp. 328–337.
[26]. Si, X., Wang, Y., Wong, J., Zhang, J., McManus, B. M., & Luo, H. (2007) Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication, Journal of Virology, vol. 81, no. 7, pp. 3142–3150.
[27]. Qin, Y., Lina, L., Chen, Y., Wu, S., Si, X., Wu, H., Zhai, X., Wang, Y., Tong, L., Pan, B., Zhong, X., Wang, T., Zhao, W., & Zhong, Z. (2014) Curcumin inhibits the replication of enterovirus 71 in vitro, Acta Pharmaceutica Sinica B, vol. 4, no. 4, pp. 284–294.
[28]. Rechtman, M. M., Har-Noy, O., Bar-Yishay, I., Fishman, S., Adamovich, Y., Shaul, Y., Halpern, Z., & Shloma, A. (2010) Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α, FEBS Letters, vol. 584, no. 11, pp. 2485–2490.
[29]. Kutluay, S. B., Doroghazi, J., Roemer, M. E., & Triezenberg, S. J. (2008) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity, Virology, vol. 373, no. 2, pp. 239–247.
[30]. Mishra A., & Das, B. C. (2015) Curcumin as an anti-human papillomavirus and anti-cancer compound, Future Oncology, vol. 11, no. 18, pp. 2487–2490
[31]. Teymouri, M., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features, BioFactors, vol. 43, no. 3, pp. 331–346.
[32]. Wen, C. C., Kuo, Y. H., Jan, J. T., Liang, P. H., Wang, S. Y., Liu, H. G., Lee, C. K., Chang, C. J., Kuo, S. T., Lee, S. S., Hou, C. C., Hsiao, P. W., Chien, S. C., Shyur L. F., & Yang, N. S. (2007) Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus, Journal of Medicinal Chemistry, vol. 50, no. 17, pp. 4087–4095.
[33]. Kandeel M., & Al-Nazawi, M. (2020) Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease, Life Sciences, vol. 251, pp. 117627-117632.
[34]. Elfiky, A. A. (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19, Life Sciences, vol. 248, pp 117477-117483.
[35]. Mohammadian, M., Moghadam, M., Salami, M., Emam-Djomeh, Z., Alavi, F., Momen, S., & Moosavi-Movahedi, A. A. (2020) Whey protein aggregates formed by non-toxic chemical cross-linking as novel carriers for curcumin delivery: Fabrication and characterization, Journal of Drug Delivery Science and Technology, vol. 56, pp. 101531-101542.
[36]. Moghadam, M., Salami, M., Mohammadian, M., Delphi, L., Sepehri, H., Emam-Djomeh, Z., & Moosavi-Movahedi,A. A. (2020) Walnut protein–curcumin complexes: fabrication, structural characterization, antioxidant properties, and in vitro anticancer activity, Journal of Food Measurement and Characterization, vol. 14, no. 2, pp. 876–885.
[37]. Singh, R. K., Rai, D., Yadav, D., Bhargava, A., Balzarini, J., & De Clercq, E. (2010) Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid, European Journal of Medicinal Chemistry, vol. 45, no. 3, pp. 1078–1086.
[38]. Richart, S. M., Li, Y. L., Mizushina, Y., Chang, Y. Y., Chung, T. S., Chen, G. H., Tzen, J. T. C., Shia, K. S., & Hsu, W. L., (2018) Synergic effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection, Journal of Food and Drug Analysis, vol. 26, no. 3, pp. 1015–1023.
[39]. Marbawati D., & Umniyati, S. R. (2015) Effects of Curcumin and Pentagamavunon-0 Against Dengue-2 Virus Infection in Vero Cells; an in Vitro Study, Procedia Environmental Science, vol. 23, no. Ictcred 2014, pp. 215–221.
[40]. Esmaili, M., Ghaffari, M., Moosavi-Movahedi, Z., Atri, M. S., Sharifizadeh, A., Farhadi, M., Yousefi. R., Chobert, J. M., Haertlé, T., & Moosavi-Movahedi A. A. (2011) Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application, LWT - Food Science and Technology, vol. 44, no. 10, pp. 2166–2172.
[41]. Ting, D., Dong, N., Fang, L., Lu, J., Bi, J., Xiao, S., & Han, H. (2018) Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin, ACS Applied Nano Materials, vol. 1, no. 10, pp. 5451–5459.
[42]. Yang, X. X., Li, M. C., & Huang, C. Z. (2016) Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection, Nanoscale, vol. 8, no. 5, pp. 3040–3048, 2016.